Daphnetin Alleviates Liver Fibrosis by Inducing Ferritinophagy‐Mediated Ferroptosis in Activated Hepatic Stellate Cells
Phytotherapy Research · 2026-02 · 40 (2) · 473-487
DOI: 10.1002/ptr.70134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 05.12.2025. Verfasst von Laiyu Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Liver Diseases, The First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Ferroptosis, Umbelliferones, Liver Cirrhosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Natural Science Foundation of Jilin Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Liver fibrosis is an increasingly serious global health issue, and an effective treatment strategy is to inhibit the activation of hepatic stellate cells (HSCs). The role of daphnetin (Daph), which is a natural coumarin derivative isolated from plants of the genus Daphne, in the treatment of hepatic fibrosis is still unclear. Mice were treated with carbon tetrachloride (CCl 4 ), and the inhibitory effect of Daph on hepatic fibrosis was evaluated. In vitro, the effect of Daph on the activated human HSCs line LX‐2 was studied. In vivo, Daph alleviated collagen accumulation and reduced the expression of fibrotic genes. However, these changes were reversed with ferrostatin‐1 (Fer‐1). In vitro, Daph induced ferroptosis in LX‐2 cells, which was characterized by increased lipid peroxidation and iron accumulation. However, deferoxamine (DFO) and Fer‐1 partially abrogated the antifibrotic effect of Daph. Mechanically, Daph exerted an antifibrotic effect by ubiquitinating glutathione peroxidase 4 (GPX4) and stimulating ferritinophagy‐mediated ferroptosis in HSCs. These results indicated that Daph promoted the ubiquitination of GPX4 and ferritinophagy‐mediated ferroptosis in HSCs, which could provide new clues for further pharmacological research on the antifibrotic effect of Daph.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Liver Diseases, The First Hospital of Jilin University, Changchun, China.
- Jilin Provincial Key Laboratory of Women's Reproductive Health, The First Hospital of Jilin University, Changchun, Jilin, China.
- Central Sterile Supply Department, The First Hospital of Jilin University, Changhun, Jilin, China.
ORCID-Profile: Xinxin Ci
Förderung
- Natural Science Foundation of Jilin Province
- National Natural Science Foundation of China
Zitieren
APA
Zhu, L., Wu, Y., Chang, S., & Ci, X. (2026). Daphnetin Alleviates Liver Fibrosis by Inducing Ferritinophagy‐Mediated Ferroptosis in Activated Hepatic Stellate Cells. Phytotherapy Research, 40(2), 473-487. https://doi.org/10.1002/ptr.70134
Vancouver
Zhu L, Wu Y, Chang S, Ci X. Daphnetin Alleviates Liver Fibrosis by Inducing Ferritinophagy‐Mediated Ferroptosis in Activated Hepatic Stellate Cells. Phytotherapy Research. 2026;40(2):473-487. doi:10.1002/ptr.70134
BibTeX
@article{Zhu2026,
author = {Zhu, Laiyu and Wu, You and Chang, Sainan and Ci, Xinxin},
title = {Daphnetin Alleviates Liver Fibrosis by Inducing Ferritinophagy‐Mediated Ferroptosis in Activated Hepatic Stellate Cells},
journal = {Phytotherapy Research},
year = {2026},
volume = {40},
number = {2},
pages = {473--487},
doi = {10.1002/ptr.70134}
}
EUVIMED